Explore federal awards
Date filters select awards with transaction activity in the period. Amounts below are lifetime award obligations. IDV values remain separate.
Export these results to CSV · 15 matching records
DIVISION OF MICROBIOLOGY AND INFECTIOUS DISEASES: REGULATORY AFFAIRS SUPPORTDepartment of Health and Human Services$18.0M obligationsEnds Jun 30, 2027
CLINICAL RESEARCH OPERATIONS AND MANAGEMENT SUPPORT (CROMS)Department of Health and Human Services$72.7M obligationsEnds Mar 31, 2027
PURPOSE: TO PROVIDE CLINICAL TRIALS SPONSOR AND REGULATORY MANAGEMENT SUPPORT SERVICES TO THE NCI, THE CENTER FOR CANCER RESEARCH (CCR), AND CCR INVESTIGATORS.Department of Health and Human Services$71.3M obligationsEnds Jun 30, 2027
TASK ORDER 1A -PROJECT KICKOFF MEETING AND TASK ORDER 5A: CENTRALIZED PROTOCOL WRITING SUPPORT; CONTRACT TITLE: CANCER TRIALS SUPPORT UNIT CTSU.Department of Health and Human Services$4.0M obligationsEnds Jul 31, 2027
PHARMACOKINETIC ANALYSIS RESOURCE CENTER. PHASE I SINGLE ASCENDING DOSE STUDY. MAY 15, 2025 - NOVEMBER 14, 2026. N01DA-25-8947. TASK ORDER 75N95025F00001 (TO1).Department of Health and Human Services$487.8K obligationsEnds Nov 14, 2028
PHARMACOKINETIC ANALYSIS RESOURCE CENTER. PHASE I CLINICAL PHARMACOLOGY/PHARMACOKINETIC STUDY. JULY 23, 2025 - JANUARY 22, 2026. N01DA-25-8947. TASK ORDER 75N95025F00002 (TO2).Department of Health and Human Services$11.1K obligationsEnds Jul 31, 2027
PHARMACOKINETIC ANALYSIS RESOURCE CENTER. OTHER SUPPORT SERVICES. JULY 23, 2025 - JULY 22, 2026. N01DA-25-8947. TASK ORDER 75N95025F00003 (TO3).Department of Health and Human Services$36.1K obligationsEnds Jul 22, 2027
DRUG DEVELOPMENT SUPPORT FOR CTEPDepartment of Health and Human Services$39.3M obligationsEnds Jun 30, 2027
THE PURPOSE OF THIS TASK ORDER IS TO FUND THE GUARANTEED MINIMUM AMOUNT OF THE CONTRACT.Department of Health and Human Services$1.1M obligationsEnds Aug 7, 2027
TASK ORDER 4. PHARMACOKINETIC ANALYSIS RESOURCE CENTER. PHASE III PROTOCOL (STP7). JUNE 5, 2026 - MARCH 4, 2027. N01DA-25-8947. TASK ORDER 75N98026F00001 (TO2).Department of Health and Human Services$11.4K obligationsEnds Mar 4, 2027
PHASE I SINGLE ASCENDING DOSE STUDY. TO7. NIDA PHARMACOKINETIC ANALYSIS RESOURCE CENTER. 09/10/2024 - 03/09/2026. NIDA REF. NO. N01DA-19-8947.Department of Health and Human Services$415.7K obligationsEnds Mar 8, 2027
PHASE I COCAINE DRUG INTERACTION STUDY. TO6. NIDA PHARMACOKINETIC ANALYSIS RESOURCE CENTER. 08/10/2023 - 02/09/2025. NIDA REF. NO. N01DA-19-8947.Department of Health and Human Services$269.7K obligationsEnds Oct 31, 2025
FY20. TO3. NIDA PHARMACOKINETIC ANALYSIS RESOURCE CENTER. NIDA REF. NO. N01DA-19-8947. PERIOD OF PERFORMANCE: 09/01/2020 TO 02/28/2022.Department of Health and Human Services$416.6K obligationsEnds Oct 31, 2025
THE PURPOSE OF THE TO REQUIREMENT IS TO CONDUCT A PHASE I STUDY OF CBD-MORPHINE DRUG-DRUG INTERACTION. TRI HAS CLEARLY DEFINED THE OBJECTIVES OF THE TO IN THEIR PROPOSAL…Department of Health and Human Services$268.7K obligationsEnds Sep 19, 2024
FY21. TO4. NIDA PHARMACOKINETIC ANALYSIS RESOURCE CENTER. NIDA REF. NO. N01DA-19-8947.Department of Health and Human Services$28.4K obligationsEnds Feb 9, 2025